Cancer-associated IDH1 mutations produce 2-hydroxyglutarate-Reference-Cited by-同舟云学术

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate

Published:2009-11-22 Issue:7274 Volume:462 Page:739-744
ISSN:0028-0836
Container-title:Nature
language:en
Short-container-title:Nature

Author:

Dang Lenny,White David W.,Gross Stefan,Bennett Bryson D.,Bittinger Mark A.,Driggers Edward M.,Fantin Valeria R.,Jang Hyun Gyung,Jin Shengfang,Keenan Marie C.,Marks Kevin M.,Prins Robert M.,Ward Patrick S.,Yen Katharine E.,Liau Linda M.,Rabinowitz Joshua D.,Cantley Lewis C.,Thompson Craig B.,Vander Heiden Matthew G.,Su Shinsan M.

Publisher

Springer Science and Business Media LLC

Subject

Multidisciplinary

Link

http://www.nature.com/articles/nature08617.pdf

Reference26 articles.

1. Balss, J. et al. Analysis of the IDH1 codon 132 mutation in brain tumors. Acta Neuropathol. 116, 597–602 (2008)

2. Watanabe, T., Nobusawa, S., Kleihues, P. & Ohgaki, H. IDH1 mutations are early events in the development of astrocytomas and oligodendrogliomas. Am. J. Pathol. 174, 1149–1153 (2009)

3. Yan, H. et al. IDH1 and IDH2 mutations in gliomas. N. Engl. J. Med. 360, 765–773 (2009)

4. Hartmann, C. et al. Type and frequency of IDH1 and IDH2 mutations are related to astrocytic and oligodendroglial differentiation and age: a study of 1,010 diffuse gliomas. Acta Neuropathol. 118, 469–474 (2009)

5. Parsons, D. W. et al. An integrated genomic analysis of human glioblastoma multiforme. Science 321, 1807–1812 (2008)

Cited by 3151 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Metabolomics and racial disparities in bladder cancer carcinogenesis;Metabolomics of Bladder Cancer;2025

2. Replenishment of TCA cycle intermediates and long-noncoding RNAs regulation in breast cancer;Molecular and Cellular Endocrinology;2024-10

3. Potential Correlation between Gene Mutations and Metabolic Changes in Acute Myeloid Leukemia;The Natural Products Journal;2024-10

4. Translational Research Platform for Malignant Central Nervous System Tumors;Neurologia medico-chirurgica;2024-09-15

5. Advances in the treatment of IDH-mutant gliomas;Current Opinion in Neurology;2024-09-12